Rafivirumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | rabies virus glycoprotein |
| Clinical data | |
| Identifiers | |
944548-37-2  | |
| None | |
| UNII |
F6G4126BPE  |
| Chemical data | |
| Formula | C6462H9954N1718O2036S46 |
| 145.8 kDa | |
| (what is this?) (verify) | |
Rafivirumab is a monoclonal antibody for the prophylaxis of rabies.[1]
References
- ↑ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
| ||||||||||||||||||||||||||||||||||||||||||||||||||